课题基金 / 基金详情

BETA LACTAMASE MUTATIONS IN ANTIBIOTIC RESISTANCE

BETA LACTAMASE MUTATIONS IN ANTIBIOTIC RESISTANCE
抗生素耐药性中的 β 内酰胺酶突变
批准号:
2067899
负责人:
Timothy Palzkill
金额:
$18.1万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-07-01 至 1996-04-30

项目摘要

项目成果

Timothy Palzkill的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The goal of the proposed research is to characterize at the molecular level how mutations can alter the substrate profile of the clinically important TEM-1 beta-lactamase. These specific questions will be addressed: 1. What beta-lactamase mutations cause an increase in resistance to beta-lactam antibiotics? Every amino acid position in TEM-1 beta-lactamase will be randomized to sample all possible amino acid substitutions using a novel mutagenesis technique. All of the random substitutions will then be screened to identify those amino acid substitutions that result in increased beta-lactamase activity towards a set of clinically relevant beta-lactam antibiotics. 2. How do mutations change the substrate spectrum of beta-lactamase? Biochemical methods will be used to further characterize the new hydrolytic capacities of the specificity mutants. These studies will include purification of the mutant proteins and determination of kinetic parameters. The conformational stability of the mutant proteins also will be determined by a variety of methods. 3. What beta-lactamase mutations result in increase antibiotic resistance in clinical isolates? The information obtained from the above studies will be used to design oligonucleotide probes that will specifically detect genes encoding specificity mutants among TEM beta-lactamase-containing clinical isolates. The studies will test the predictive capacity of the random substitution experiments and provide specific information about the mechanisms of beta-lactam antibiotic resistance. In total, these studies will assess systematically the ability of TEM-1 beta-lactamase to expand its substrate spectrum by mutation. The information gained in these studies will be of immediate empirical value in predicting the susceptibility of a given antibiotic to mutational changes in the beta-lactamase. In the long term we would like to use the data to predict how beta-lactamase will respond to the selective pressure of antibiotic therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Using DNA-encoded Chemical Libraries to Develop Inhibitors of the MCR-1 Colistin Resistance Enzyme
  • 批准号:
    10613563
  • 项目类别:
  • 资助金额:
    $20.0万
  • 财政年份:
    2022
  • 负责人:
    Timothy Palzkill
  • 依托单位:
Using DNA-encoded Chemical Libraries to Develop Inhibitors of the MCR-1 Colistin Resistance Enzyme
  • 批准号:
    10433324
  • 项目类别:
  • 资助金额:
    $24.0万
  • 财政年份:
    2022
  • 负责人:
    Timothy Palzkill
  • 依托单位:
Discovery of Carbapenemase Inhibitors Using DNA-Encoded Chemical Libraries
  • 批准号:
    10078242
  • 项目类别:
  • 资助金额:
    $60.43万
  • 财政年份:
    2019
  • 负责人:
    Timothy Palzkill
  • 依托单位:
Discovery of Carbapenemase Inhibitors Using DNA-Encoded Chemical Libraries
  • 批准号:
    10538574
  • 项目类别:
  • 资助金额:
    $60.43万
  • 财政年份:
    2019
  • 负责人:
    Timothy Palzkill
  • 依托单位:
海外基金